Detalhe da pesquisa
1.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697469
2.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 196(1): 136-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496035
3.
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Br J Haematol
; 193(4): 779-791, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876423
4.
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.
Eur J Haematol
; 97(5): 471-478, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028202
5.
An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia.
Am J Hematol
; 96(1): E17-E20, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021743
6.
Changing frontline AML treatment patterns from 2013 to 2022.
Leuk Res
; 132: 107354, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467567
7.
Familial myelodysplastic syndromes: a review of the literature.
Haematologica
; 96(10): 1536-42, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606161
8.
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI.
Leuk Res
; 111: 106674, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333277
9.
Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia.
Leuk Res
; 45: 47-52, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092851
10.
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
Clin Lymphoma Myeloma Leuk
; 15(12): 715-27, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26433906
11.
Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol.
Leuk Res
; 37(12): 1632-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24199709
12.
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen.
Leuk Res
; 36(12): 1517-20, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22940259